Subscribe

Spotlight -

This Year In Medicine 2025

AAAI/WAO 2018 Perspectives

AAAI/WAO 2018 Perspectives

Episodes

Specialty:

All

Year:

All

EP. 1: Environmental Interventions Are Effective in Both Cost and Outcomes

March 20th 2018

EP. 2: Wanda Phipatanakul, MD, MS: The Need for Pollution-Based Health Research

March 20th 2018

EP. 3: Claus Bachert, MD, PhD: Why Monoclonal Antibodies Work for Asthma

March 20th 2018

EP. 4: Mepolizumab: A Proven Alternative to Omalizumab

March 20th 2018

EP. 5: US, UK Studies Examine Whether Increasing Glucocorticoid Reduces Asthma Exacerbations

March 20th 2018

EP. 6: Unnatural Allergen Eases Grass Pollen Allergy

March 20th 2018

EP. 7: Clearing the Air on Effects of Smoking in Asthma

March 20th 2018

EP. 8: Monitoring FeNO Reduces Asthma Hospitalizations, Saves Costs

March 20th 2018

EP. 9: Marc Massanari, PharmD: The History of Inflammation in Asthma

March 20th 2018

EP. 10: Allergic Multimorbidity May Cause More Severe Allergic Disease

March 20th 2018

EP. 11: Eosinophilic Disorder Therapy AK002 Shows Success in Phase 1

March 20th 2018

EP. 12: Jonathan Spergel, MD, PhD: The Takeaways from AAAAI/WAO 18

March 20th 2018

EP. 13: Jonathan Spergel, MD, PhD: Environmental Controls and Cost-Effectiveness in Allergy

March 20th 2018

EP. 14: Jonathan Spergel, MD, PhD: Interdisciplinary Care and Personalized Medicine for Allergy

March 20th 2018

Trending on HCPLive

Brensocatib Patient Selection Evolves 1 Year After FDA Approval

CKM Syndrome, Artery Damage Prevalence Higher in Young Adults than Previously Believed

ABTECT Maintenance Data Show Durable Remission in UC, With Remo Panaccione, MD

Why Mentorship Matters Most for Dermatology Trainees

The HCPFive: Top News for Healthcare Providers from the Week of 08/16